Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim West

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Annals of Clinical and Translational Neurology|March 28, 2023
Independent study demonstrates amyloid probability score accurately indicates amyloid pathologyIlana Fogelman, Tim West, Joel B Braunstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 17, 2024
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trialDoris Patricia Molina-Henry, Rema Raman, Andy Liu, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 29, 2026
Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's diseaseJulie Lee, Emily Olafson, Balazs Toth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2025
Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PETPetrice M Cogswell, Heather J Wiste, Stephen D Weigand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 30, 2021
Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working groupInge M W Verberk, Els O Misdorp, Jannet Koelewijn, et al.
Sleep|November 27, 2023
Associations of sleep duration and daytime sleepiness with plasma amyloid beta and cognitive performance in cognitively unimpaired, middle-aged and older African AmericansJesse D Cook, Ammara Malik, David T Plante, et al.
Nature Reviews. Neurology|June 22, 2019
SILK studies - capturing the turnover of proteins linked to neurodegenerative diseasesRoss W Paterson, Audrey Gabelle, Brendan P Lucey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2023
Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's diseaseRobert A Rissman, Oliver Langford, Rema Raman, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Annals of Clinical and Translational Neurology|March 28, 2023
Independent study demonstrates amyloid probability score accurately indicates amyloid pathologyIlana Fogelman, Tim West, Joel B Braunstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 17, 2024
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trialDoris Patricia Molina-Henry, Rema Raman, Andy Liu, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 29, 2026
Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's diseaseJulie Lee, Emily Olafson, Balazs Toth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2025
Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PETPetrice M Cogswell, Heather J Wiste, Stephen D Weigand, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 30, 2021
Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working groupInge M W Verberk, Els O Misdorp, Jannet Koelewijn, et al.
Sleep|November 27, 2023
Associations of sleep duration and daytime sleepiness with plasma amyloid beta and cognitive performance in cognitively unimpaired, middle-aged and older African AmericansJesse D Cook, Ammara Malik, David T Plante, et al.
Nature Reviews. Neurology|June 22, 2019
SILK studies - capturing the turnover of proteins linked to neurodegenerative diseasesRoss W Paterson, Audrey Gabelle, Brendan P Lucey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2023
Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's diseaseRobert A Rissman, Oliver Langford, Rema Raman, et al.
Pageof 5